Clinical trial

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

NCT01134523

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE3

Study timeline

Study start (unknown)2010-05-01Date precision: month

Registry last updated2013-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Epirubicin, CTX, PaclitaxelDRUG

Epirubicin, PaclitaxelDRUG

Sponsors & collaborators

Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01134523 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.